Sanjay Ramakrishnan
@sanjayresp
Academic Respiratory Physician @Charlies_Resp & @Resp_Health | Senior Lecturer @uwanews | #NewPI #COPD #Asthma 🇦🇺 🇲🇾
ID: 230117480
24-12-2010 09:43:09
1,1K Tweet
1,1K Followers
1,1K Following
Sanjay Ramakrishnan Mona Bafadhel The Lancet Respiratory Medicine Congrats team, great study!
ABRA trial for people with eosinophilia acute asthma or COPD a single dose of benralizumab was superior to prednisone preventing treatment failure Odds ratio 0.26 95%ci 0.125, 0.57 #ers2024 Mona Bafadhel Sanjay Ramakrishnan
Sanjay Ramakrishnan Mona Bafadhel The Lancet Respiratory Medicine Great study! Congratulations !
ABRA Trial : Huge strides in management of acute exacerbation of eosinophilic asthma/ COPD. 1 dose of Benralizumab far superior than oral steroids! Well done & congratulations Mona Bafadhel Sanjay Ramakrishnan ERS
Time to unchain our COPD patients from the steroid burden of existing exacerbation treatments - powerful words from the amazing Mona Bafadhel #ERSCongress2024
Sanjay Ramakrishnan Mona Bafadhel Congratulations Sanjay! 🥳 Excellent study!
Sanjay Ramakrishnan Mona Bafadhel The Lancet Respiratory Medicine Well done for this brilliant trial and results!
Congrats Sanjay Ramakrishnan and Mona Bafadhel - gamechanger!!
Sanjay Ramakrishnan Mona Bafadhel The Lancet Respiratory Medicine Brilliant study, impressive results!! Congratulations!! 🎉
Sanjay Ramakrishnan Mona Bafadhel The Lancet Respiratory Medicine Amazing congrats Sanjay!!!!
Sanjay Ramakrishnan Pradeep Rajagopalan Mona Bafadhel Just, wow. Congrats.
Sanjay Ramakrishnan Congratulations! Groundbreaking work.
Great work! 🙌🏼 Sanjay Ramakrishnan and Mona Bafadhel The should be practice changing
ABRA. Simply amazing. Congratulations! Sanjay Ramakrishnan
Very exciting work from one of our academic respiratory physicians here at Charlie’s Respiratory Respiratory Health UWA Research